Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

P45481 (CBP_MOUSE) Mus musculus (Mouse)

Histone lysine acetyltransferase CREBBP UniProtKBAFDB90v4InterProSTRINGInteractive Modelling

2441 aa; Sequence (Fasta)

Available Structures

28 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
NMR structure of RelA-TAD/CBP-TAZ1 complex Heteromer
Q04207;
340-439
ZN;
Assess
NMR structure of the CBP-TAZ1/STAT2-TAD complex Heteromer
P52630;
340-439
ZN;
Assess
NMR structure of CBP TAZ1/CITED2 complex Heteromer
Q99967;
340-439
ZN;
Assess
The CBP TAZ1 Domain in Complex with a CITED2-HIF-1-Alpha Fusion Peptide Heteromer
Q16665; Q99967;
341-437
ZN;
Assess
STRUCTURAL BASIS FOR HIF-1ALPHA/CBP RECOGNITION IN THE CELLULAR HYPOXIC RESPONSE Heteromer
Q16665;
345-439
ZN;
Assess
NMR structure of the CBP-TAZ2/STAT1-TAD complex Heteromer
P42224;
1764-1855
ZN;
Assess
HBZ77 in complex with KIX and c-Myb Heteromer
P06876; Q2Q067;
586-672
EDO;
Assess
Structural basis for cooperative transcription factor binding to the CBP coactivator Heteromer
P06876; Q03164;
586-672
Assess
Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb Heteromer
P06876;
586-672
Assess
NMR structure of FOXO3a transactivation domains (CR2C-CR3) in complex with CBP KIX domain (2b3l con… Heteromer
O43524;
586-672
Assess
NMR structure of the complex between the KIX domain of CBP and the transactivation domain 1 of p65 Heteromer
Q04206;
586-672
Assess
NMR structure of FOXO3a transactivation domains (CR2C-CR3) in complex with CBP KIX domain (2l3b con… Heteromer
O43524;
586-672
Assess
HBZ56 in complex with KIX and c-Myb Heteromer
P06876; P0C746;
589-672
Assess
KIX DOMAIN OF MOUSE CBP (CREB BINDING PROTEIN) IN COMPLEX WITH PHOSPHORYLATED KINASE INDUCIBLE DOMA… Heteromer
P15337;
586-666
Assess
Mutual Synergistic Folding in the Interaction Between Nuclear Receptor Coactivators CBP and ACTR Heteromer
Q9Y6Q9;
2059-2117
Assess
Structure of CBP nuclear coactivator binding domain in complex with p53 TAD Heteromer
P04637;
2059-2117
Assess
Structural diversity in CBP p160 complexes Heteromer
Q15788;
2059-2116
Assess
Crystal Structure of the Catalytic Core of CBPmonomer1079-1556
ZN;
Assess
CREBBP Bromodomain in complex with Cpd8 (1-(3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-…monomer1085-1198
9UA;DMS;GOL;
Assess
Structure CBP TAZ1 Domainmonomer340-439
ZN;
Assess
Solution Structure of p53TAD-TAZ1monomer340-439
ZN;
Assess
Solution Structure of TAZ2-p53AD2monomer1764-1855
ZN;
Assess
Solution Structure of TAZ2-p53TADmonomer1764-1855
ZN;
Assess
SOLUTION STRUCTURE OF THE TAZ2 DOMAIN OF THE TRANSCRIPTIONAL ADAPTOR PROTEIN CBPmonomer1764-1849
ZN;
Assess
Crystal Structure of GACKIX L664C Tethered to 1-10monomer588-665
KI1;EDO;
Assess
Solution structure of the Nuclear coactivator binding domain of CBPmonomer2059-2117
Assess
ZZ Domain of CBP- a Novel Fold for a Protein Interaction Modulemonomer1700-1751
ZN;
Assess
NMR Structure of IBiD, A Domain of CBP/p300monomer2067-2112
Assess

6 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6fgs.1.Amonomer0.62346-439
ZN;31.40
Assess
6gyr.2.Amonomer0.621083-1702
ZN;84.84
Assess
8han.1.Imonomer0.601089-1701
97.77
Assess
1p4q.1.Bmonomer0.60342-438
ZN;92.78
Assess
8haj.1.Kmonomer0.601087-1702
86.99
Assess
6dmx.1.Cmonomer0.57591-671
100.00
Assess